MPNs

Latest News

Selinexor With Ruxolitinib Continues to Demonstrate Efficacy in Myelofibrosis
Selinexor With Ruxolitinib Continues to Demonstrate Efficacy in Myelofibrosis

December 11th 2024

Selinexor with ruxolitinib demonstrated encouraging efficacy with a manageable safety profile in patients with myelofibrosis who were previously treated with ruxolitinib.

Venetoclax Plus Hypomethylating Agents Show Superior Response in MDS
Venetoclax Plus Hypomethylating Agents Show Superior Response in MDS

December 10th 2024

AI-Driven Deep Learning Model Shows Promise in Standardizing MDS Diagnosis
AI-Driven Deep Learning Model Shows Promise in Standardizing MDS Diagnosis

December 10th 2024

Olverembatinib Shows Promise as Second-Line Therapy in Chronic-Phase CML
Olverembatinib Shows Promise as Second-Line Therapy in Chronic-Phase CML

December 9th 2024

Deferasirox Achieves Transfusion Independence in MDS Anemia
Deferasirox Achieves Transfusion Independence in MDS Anemia

December 9th 2024